norfloxacin has been researched along with Chronic Illness in 16 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Studies on a combination therapy of fosfomycin (FOM) and norfloxacin (NFLX) against chronic otitis media were performed, and the following results were obtained." | 7.70 | [Combination effect of fosfomycin otic solution and norfloxacin against chronic otitis media]. ( Uno, Y, 1999) |
| "We treated 15 men who had chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin with 400 mg." | 7.68 | The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin. ( Darras, FS; Schaeffer, AJ, 1990) |
| "The clinical efficacy of norfloxacin (NFLX) was evaluated in 74 patients having chronic prostatitis with the subjective symptoms suggesting the inflammations of prostate and more than five white bloodcells (WBCs)/hpf in their prostatic secretions (EPS)." | 7.67 | [The therapeutic effect of norfloxacin on chronic prostatitis]. ( Gouro, T; Henmi, I; Igawa, K; Kadono, M; Kumamoto, Y; Maekwa, S; Oguma, K; Okayama, S; Sakai, S; Tsukamoto, T, 1987) |
| "Forty-three patients admitted to hospital with acute purulent exacerbations of chronic bronchitis were treated with 400 mg pefloxacin twice daily for ten days." | 7.67 | Pefloxacin in acute exacerbations of chronic bronchitis. ( Davies, BI; Maesen, FP; Teengs, JP, 1985) |
| "Ten patients with bacterial overgrowth-related diarrhea underwent the following five 7-day treatment periods: untreated (control period), then placebo, and subsequently, in random order and blinded fashion, norfloxacin (800 mg/day), amoxicillin-clavulanic acid (1500 mg/day), and Saccharomyces boulardii (1500 mg/day)." | 5.09 | Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. ( Attar, A; Bouhnik, Y; Flourié, B; Franchisseur, C; Rambaud, JC; Ruszniewski, P, 1999) |
| "Studies on a combination therapy of fosfomycin (FOM) and norfloxacin (NFLX) against chronic otitis media were performed, and the following results were obtained." | 3.70 | [Combination effect of fosfomycin otic solution and norfloxacin against chronic otitis media]. ( Uno, Y, 1999) |
| "We treated 15 men who had chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin with 400 mg." | 3.68 | The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin. ( Darras, FS; Schaeffer, AJ, 1990) |
| "The clinical efficacy of norfloxacin (NFLX) was evaluated in 74 patients having chronic prostatitis with the subjective symptoms suggesting the inflammations of prostate and more than five white bloodcells (WBCs)/hpf in their prostatic secretions (EPS)." | 3.67 | [The therapeutic effect of norfloxacin on chronic prostatitis]. ( Gouro, T; Henmi, I; Igawa, K; Kadono, M; Kumamoto, Y; Maekwa, S; Oguma, K; Okayama, S; Sakai, S; Tsukamoto, T, 1987) |
| "Forty-three patients admitted to hospital with acute purulent exacerbations of chronic bronchitis were treated with 400 mg pefloxacin twice daily for ten days." | 3.67 | Pefloxacin in acute exacerbations of chronic bronchitis. ( Davies, BI; Maesen, FP; Teengs, JP, 1985) |
| " We employed a rat model of chronic bacterial prostatitis to investigate any pharmacokinetic differences that may exist between uninflamed and inflamed prostate glands." | 1.29 | Antibiotic pharmacokinetics in the inflamed prostate. ( Ceri, H; Clark, J; Downey, J; Nickel, JC; Olson, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (37.50) | 18.7374 |
| 1990's | 8 (50.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Molla, R | 1 |
| Tiruneh, M | 1 |
| Abebe, W | 1 |
| Moges, F | 1 |
| Mwachari, CW | 1 |
| Meier, AS | 1 |
| Muyodi, J | 1 |
| Gatei, W | 1 |
| Waiyaki, P | 1 |
| Cohen, CR | 1 |
| Peppas, T | 1 |
| Petrikkos, G | 1 |
| Deliganni, V | 1 |
| Zoumboulis, P | 1 |
| Koulentianos, E | 1 |
| Giamarellou, H | 1 |
| Nickel, JC | 1 |
| Downey, J | 1 |
| Clark, J | 1 |
| Ceri, H | 1 |
| Olson, M | 1 |
| Levadoux, M | 1 |
| Carli, P | 1 |
| Gadea, JF | 1 |
| De Mauleon De Bruyere, P | 1 |
| Perre, C | 1 |
| Sumano, LH | 1 |
| Ocampo, CL | 1 |
| Brumbaugh, GW | 1 |
| Lizarraga, RE | 1 |
| Uno, Y | 1 |
| Attar, A | 1 |
| Flourié, B | 1 |
| Rambaud, JC | 1 |
| Franchisseur, C | 1 |
| Ruszniewski, P | 1 |
| Bouhnik, Y | 1 |
| Schaeffer, AJ | 1 |
| Darras, FS | 1 |
| Morikawa, M | 1 |
| Tokunaka, S | 1 |
| Yachiku, S | 1 |
| Yamauchi, K | 1 |
| Wakabayashi, A | 1 |
| Inagaki, N | 1 |
| Nishihara, M | 1 |
| Yamaguchi, S | 1 |
| Majima, Y | 1 |
| Hirata, K | 1 |
| Takeuchi, K | 1 |
| Hattori, M | 1 |
| Sakakura, Y | 1 |
| Mertens, JC | 1 |
| Dekker, W | 1 |
| Ligtvoet, EE | 1 |
| Blok, P | 1 |
| Davies, BI | 2 |
| Maesen, FP | 2 |
| Teengs, JP | 2 |
| Baur, C | 1 |
| Comhaire, FH | 1 |
| Kumamoto, Y | 1 |
| Tsukamoto, T | 1 |
| Sakai, S | 1 |
| Gouro, T | 1 |
| Maekwa, S | 1 |
| Oguma, K | 1 |
| Henmi, I | 1 |
| Igawa, K | 1 |
| Kadono, M | 1 |
| Okayama, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Retrospective Analysis of Treatment Outcomes in Patients With Bacterial Overgrowth Syndrome Diagnosed by D-Xylose Breath Testing[NCT01324895] | 944 participants (Actual) | Observational | 2010-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for norfloxacin and Chronic Illness
| Article | Year |
|---|---|
Effectiveness of two fluoroquinolones for the treatment of chronic respiratory disease outbreak in broilers.
Topics: Animals; Anti-Infective Agents; Body Weight; Chickens; Chronic Disease; Disease Outbreaks; Enrofloxa | 1998 |
Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; | 1999 |
14 other studies available for norfloxacin and Chronic Illness
| Article | Year |
|---|---|
Bacterial profile and antimicrobial susceptibility patterns in chronic suppurative otitis media at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chronic Disease; Ciprofloxacin; Clarithromyci | 2019 |
Chronic diarrhoea in HIV-1-infected adults in Nairobi, Kenya: evaluation of risk factors and the WHO treatment algorithm.
Topics: Adult; Algorithms; Anti-Infective Agents; Chronic Disease; Cohort Studies; Diarrhea; Drug Therapy, C | 2003 |
Efficacy of long-term therapy with norfloxacin in chronic bacterial prostatitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Humans; Male; Mi | 1989 |
Antibiotic pharmacokinetics in the inflamed prostate.
Topics: Animals; Bacterial Infections; Chronic Disease; Male; Norfloxacin; Prostatitis; Rats; Rats, Sprague- | 1995 |
[Repeated rupture of the extensor tendons of the hand due to fluoroquinolones. Apropos of a case].
Topics: Acute Disease; Aged; Anti-Infective Agents; Blood Vessels; Chronic Disease; Female; Hand; Hemosidero | 1997 |
[Combination effect of fosfomycin otic solution and norfloxacin against chronic otitis media].
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Chronic | 1999 |
The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin.
Topics: Carbenicillin; Chronic Disease; Escherichia coli Infections; Follow-Up Studies; Humans; Male; Middle | 1990 |
[The therapeutic effect of norfloxacin on chronic prostatitis].
Topics: Adult; Aged; Bacterial Infections; Chronic Disease; Drug Evaluation; Humans; Leukocyte Count; Male; | 1990 |
Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Carbocysteine; Chronic Disease; El | 1990 |
Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsia.
Topics: Campylobacter Infections; Chronic Disease; Dyspepsia; Gastritis; Humans; Norfloxacin | 1989 |
[New oral quinolone compounds in chronic bronchitis].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Cipr | 1986 |
Concentration of pefloxacine in split ejaculates of patients with chronic male accessory gland infection.
Topics: Adult; Chronic Disease; Exocrine Glands; Genital Diseases, Male; Humans; Infertility, Male; Inflamma | 1987 |
[The therapeutic effect of norfloxacin on chronic prostatitis].
Topics: Adult; Aged; Chronic Disease; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Male; Micr | 1987 |
Pefloxacin in acute exacerbations of chronic bronchitis.
Topics: Anti-Bacterial Agents; Bacteria; Bronchitis; Chronic Disease; Female; Humans; Kinetics; Male; Microb | 1985 |